OncoCyte Corp (OCX): Oncocyte to Participate at 19th Annual N...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

OncoCyte Corp (OCX)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	2
Posts	628
Boards Moderated	0
Alias Born	07/11/2013

Re: None

Monday, 04/13/2020 11:53:06 AM

Monday, April 13, 2020 11:53:06 AM

Oncocyte to Participate at 19th Annual Needham Virtual Healthcare Conference

IRVINE, Calif., April 07, 2020 (GLOBE NEWSWIRE) -- Oncocyte Corporation (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer care continuum, today announced that company management will participate in the 1-on-1 meetings at the upcoming 19th Annual Needham Virtual Healthcare Conference from Tuesday, April 14, 2020 through Wednesday, April 15, 2020.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent OCX News

PRISM MarketView Spotlights Oncocyte Corporation as it Works to Disrupt the Precision Diagnostics Marketplace • GlobeNewswire Inc. • 05/07/2024 01:19:00 PM
Oncocyte Reports Full Year 2023 Financial Results • GlobeNewswire Inc. • 04/12/2024 10:00:00 AM
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules • GlobeNewswire Inc. • 04/12/2024 01:46:37 AM
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay • GlobeNewswire Inc. • 04/11/2024 09:30:00 PM
Oncocyte to Announce Fourth Quarter and Full Year 2024 Financial Results • GlobeNewswire Inc. • 04/09/2024 08:05:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 09:39:38 PM
Oncocyte to Present at the Sequire Investor Summit in Puerto Rico • GlobeNewswire Inc. • 01/16/2024 01:00:00 PM
Oncocyte Begins FDA Submissions Process for VitaGraft Transplant Assays • GlobeNewswire Inc. • 12/06/2023 01:00:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 10:19:59 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 12:05:24 PM
Oncocyte Reports Third Quarter 2023 Financial Results • GlobeNewswire Inc. • 11/09/2023 12:00:00 PM
Oncocyte to Announce Third Quarter 2023 Financial Results • GlobeNewswire Inc. • 11/03/2023 12:30:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/12/2023 08:30:57 PM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 10/10/2023 08:48:39 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/05/2023 08:05:37 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2023 01:00:16 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 08:05:23 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/17/2023 10:57:33 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:50:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 11:05:36 AM
VitaGraft Kidney Expands Utility in Recurrent Primary Disease Patients • GlobeNewswire Inc. • 07/25/2023 01:08:17 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/24/2023 09:28:38 PM
Oncocyte Announces 1-For-20 Reverse Stock Split • GlobeNewswire Inc. • 07/24/2023 05:35:32 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 07/21/2023 09:16:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/14/2023 10:03:15 AM

More OCX News

InvestorsHub NewsWire

FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow